Next Steps When Nurtec (Rimegepant) Fails
If Nurtec (rimegepant) is not providing adequate relief for acute migraine treatment, the next step is to combine a triptan with an NSAID (such as sumatriptan 50-100 mg plus naproxen sodium 500 mg), which represents the most effective acute treatment strategy and should be taken early in the attack while pain is still mild. 1, 2, 3
Immediate Treatment Adjustments
Optimize Current Rimegepant Use First
Before abandoning rimegepant entirely, ensure you are:
- Taking it early in the headache phase while pain is still mild, as late administration significantly reduces response rates 1, 2, 3
- Using it for the appropriate indication (rimegepant is FDA-approved for both acute treatment and prevention when taken every other day) 4, 5
- Not overusing acute medications (≥10 days/month creates medication overuse headache) 1, 6
Escalate to Triptan + NSAID Combination
The combination of a triptan with an NSAID is superior to either agent alone and represents the strongest evidence-based recommendation for moderate to severe migraine. 1, 2, 3
Specifically:
- Sumatriptan 50-100 mg PLUS naproxen sodium 500 mg produces 130 additional patients per 1000 achieving sustained pain relief at 48 hours compared to monotherapy 3
- This combination should be your next step if rimegepant alone is insufficient 1, 2
- Take early in the attack for maximum effectiveness 1, 2
If One Triptan Fails, Try Another
Failure of one triptan does not predict failure of others within the class. 3, 7
Available triptans include:
- Sumatriptan, rizatriptan, eletriptan, zolmitriptan, almotriptan, frovatriptan, or naratriptan 1, 2
- Consider non-oral routes (subcutaneous, intranasal) if severe nausea/vomiting is present 2, 6
Alternative CGRP Antagonists (Gepants)
If rimegepant specifically is not working, consider other gepants:
- Ubrogepant or zavegepant (intranasal) are alternative CGRP antagonists 1, 2
- These remain third-line options after triptan + NSAID combination failure 1, 2
Fourth-Line Option: Lasmiditan
Lasmiditan (a ditan) should be reserved for patients who do not tolerate or have inadequate response to all other treatments including triptan + NSAID combinations and other gepants. 1
Critical caveat:
- Patients cannot operate machinery for at least 8 hours after intake due to driving impairment 1
Preventive Therapy Consideration
If you are treating frequent attacks (≥2 migraine days per month with significant disability), you need preventive therapy in addition to optimizing acute treatment. 1, 2, 6
First-line preventive options:
- Propranolol 80-240 mg/day or timolol 20-30 mg/day 6, 3
- Topiramate (requires 2-3 months for efficacy assessment) 6, 3
- Amitriptyline 30-150 mg/day (especially if mixed migraine and tension headache) 6, 3
- OnabotulinumtoxinA for chronic migraine (≥15 headache days/month) 6, 3
Note: Rimegepant 75 mg every other day is also FDA-approved for migraine prevention and may be more effective than acute use alone 4, 8, 5
Critical Pitfalls to Avoid
Medication Overuse Headache
Strictly limit all acute migraine medications to no more than 2 days per week. 3
- NSAIDs trigger medication overuse headache at ≥15 days/month 1, 6, 3
- Triptans and gepants trigger it at ≥10 days/month 1, 6, 3
- This creates a vicious cycle where increased medication use paradoxically worsens headache frequency 3
Medications to Absolutely Avoid
Do not use opioids or butalbital for migraine treatment. 1, 2
- These have questionable efficacy, risk of dependency, and promote medication overuse headache 1, 3
- Oral ergot alkaloids are poorly effective and potentially toxic 1
Adjunct Medications
For nausea/vomiting:
- Metoclopramide 10 mg (has direct analgesic effects through dopaminergic receptor antagonism) 1, 2, 3
- Domperidone as alternative 1, 2
When to Reassess
Evaluate treatment response 2-3 months after any change in strategy, then every 6-12 months. 1, 6
Use headache calendars to track:
- Attack frequency (migraine days per month) 1, 6
- Attack severity and pain intensity 1, 6
- Acute medication use patterns 1, 6
If all treatments fail after thorough optimization, the diagnosis should be questioned and specialist referral is indicated. 1